Amgen (NASDAQ: AMGN) outlined the company's long-term strategy during a Business Review meeting with analysts and investors in New York ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE